Your browser doesn't support javascript.
loading
Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis.
Pastor, Marta; Moreno-Sastre, María; Esquisabel, Amaia; Sans, Eulàlia; Viñas, Miguel; Bachiller, Daniel; Asensio, Víctor José; Pozo, Angel Del; Gainza, Eusebio; Pedraz, José Luis.
Afiliación
  • Pastor M; NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque Country, School of Pharmacy, Paseo de la Universidad 7, Vitoria-Gasteiz 01006, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain. Electronic address
  • Moreno-Sastre M; NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque Country, School of Pharmacy, Paseo de la Universidad 7, Vitoria-Gasteiz 01006, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain. Electronic address
  • Esquisabel A; NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque Country, School of Pharmacy, Paseo de la Universidad 7, Vitoria-Gasteiz 01006, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain. Electronic address
  • Sans E; Department of Pathology and Experimental Therapeutics, Medical School, University of Barcelona - IDIBELL, Barcelona, Spain.
  • Viñas M; Department of Pathology and Experimental Therapeutics, Medical School, University of Barcelona - IDIBELL, Barcelona, Spain.
  • Bachiller D; Fundación Investigaciones Sanitarias Islas Baleares (FISIB), Development and Regeneration Program, Ctra. Sóller km 12, Bunyola (Balearic Islands) 07110, Spain; Consejo Superior de Investigaciones Científicas (CSIC), Ctra. Sóller km 12, Bunyola (Balearic Islands) 7110, Spain.
  • Asensio VJ; Fundación Investigaciones Sanitarias Islas Baleares (FISIB), Development and Regeneration Program, Ctra. Sóller km 12, Bunyola (Balearic Islands) 07110, Spain.
  • Pozo AD; B.R.A.I.E., Hermanos Lumiere 5, Miñao 01510, Spain.
  • Gainza E; B.R.A.I.E., Hermanos Lumiere 5, Miñao 01510, Spain.
  • Pedraz JL; NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque Country, School of Pharmacy, Paseo de la Universidad 7, Vitoria-Gasteiz 01006, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain. Electronic address
Int J Pharm ; 477(1-2): 485-94, 2014 Dec 30.
Article en En | MEDLINE | ID: mdl-25445528
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Plantas_medicinales Asunto principal: Pseudomonas aeruginosa / Infecciones por Pseudomonas / Portadores de Fármacos / Colistina / Fibrosis Quística / Nanopartículas / Lípidos / Antibacterianos Tipo de estudio: Risk_factors_studies Idioma: En Revista: Int J Pharm Año: 2014 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Plantas_medicinales Asunto principal: Pseudomonas aeruginosa / Infecciones por Pseudomonas / Portadores de Fármacos / Colistina / Fibrosis Quística / Nanopartículas / Lípidos / Antibacterianos Tipo de estudio: Risk_factors_studies Idioma: En Revista: Int J Pharm Año: 2014 Tipo del documento: Article